SCHEMBL1709802

SCHEMBL1709802

CCc1csc([C@H](Cc2ccc(NS(=O)(=O)O)cc2)NC(=O)CCC(=O)O)n1

nearest known ligand 0.81

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
PTPRB P23467 20/20 0.81

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL500711 0.91 PTPRB (0.76) PTPRB
SCHEMBL500710 0.91 PTPRB (0.76) PTPRB
SCHEMBL468284 0.90 PTPRB (0.81) PTPRB
SCHEMBL468286 0.90 PTPRB (0.81) PTPRB
SCHEMBL468274 0.90 PTPRB (1.00) PTPRB
SCHEMBL468276 0.90 PTPRB (1.00) PTPRB
SCHEMBL500484 0.89 PTPRB (0.73) PTPRB
SCHEMBL500485 0.89 PTPRB (0.73) PTPRB
SCHEMBL684547 0.89 PTPRB (0.82) PTPRB
SCHEMBL500468 0.88 PTPRB (1.00) PTPRB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2012047966-A2 COMPOSITIONS AND METHODS FOR TREATING OCULAR EDEMA, NEOVASCULARIZATION AND RELATED DISEASES AKEBIA THERAPEUTICS INC. (US) 2012-04-12 WO disclosed